Program Overview

Master of Advanced Studies (MA) in Versicherungsmedizin

The Master of Advanced Studies (MA) in Versicherungsmedizin is a postgraduate program designed to address the growing demand for highly qualified professionals in insurance medicine. The program is offered in cooperation with the University of Basel and other partner institutions in Switzerland and Germany.

Program Structure

The program is modular and consists of basic modules taught in Basel, as well as advanced modules and seminars. The curriculum includes courses on health care, social insurance, personal and liability insurance, and prevention. The program also features international modules, where students can compare different systems in Austria, Switzerland, and Germany.

Duration and Language

The program lasts for 6 semesters (60 ECTS) and is taught in German. The next start date is October 2026, with a new cohort beginning every 2 years.

Tuition Fees

The tuition fees for the program are CHF 36,000.

Leadership

The program is led by lic. iur. Yvonne Bollag.

Topics

The program covers a range of topics, including:

• Health care
• Social insurance
• Personal and liability insurance
• Prevention

Curriculum

The curriculum is designed to provide students with a comprehensive understanding of insurance medicine, including:

• Basismodule (basic modules)
• Advanced modules
• Seminars
• International modules

Expertise

The program is taught by over 100 renowned experts from universities, health authorities, social and private insurance companies, who provide students with the latest research findings and practical knowledge.

Qualification

Upon completion of the program, students can earn a Master of Advanced Studies (MAS) in Versicherungsmedizin. It is also possible to complete individual modules and earn a Diploma of Advanced Studies (DAS) or a Certificate of Advanced Studies (CAS) with a specific focus.

Cooperation

The program is offered in cooperation with the University of Basel and other partner institutions in Switzerland and Germany.